生物可吸收血管支架市場規模、佔有率和成長分析：按產品類型、材料類型、應用、最終用戶、支架類型、藥物類型和地區分類－2026-2033年產業預測

2024 年全球生物可吸收血管支架 (BVS) 市場價值為 3.01 億美元，預計到 2025 年將成長至 3.314 億美元，到 2033 年將成長至 7.1557 億美元，在預測期（2026-2033 年）內複合成長率為 10.1%。

生物可吸收血管支架（BVS）的全球市場正日益受到關注，因為這些創新裝置能夠為冠狀動脈提供暫時支撐，並隨著時間的推移而溶解，從而減輕與永久性金屬支架相關的長期併發症。尤其是在老年複雜冠狀動脈疾病患者對生物相容性解決方案的需求不斷成長的情況下，BVS技術能夠有效應對血管再阻塞和支架血栓症形成延遲等挑戰，同時改善血管功能。微創心臟治療的興起正在推動BVS的普及，領先的製造商正加大對先進材料的研發投入。此外，人工智慧透過計算建模革新支架設計，縮短創新週期，改善治療效果。這正在加速開發出滿足嚴格監管要求和市場需求的多樣化高性能支架。

全球生物可吸收血管支架市場促進因素

全球生物可吸收血管支架市場的主要促進因素是心血管疾病的日益流行，這推動了對創新有效療法的需求。隨著醫療專業人員尋求傳統藥物釋放型支架的替代方案，生物可吸收支架因其能夠為血管提供暫時支撐，同時促進自然癒合並減少長期併發症而備受關注。此外，材料科學和技術的進步正在提高這些支架的性能和安全性，進一步促進其在臨床實踐中的應用。個人化醫療和以病人為中心的照護方法的日益普及也進一步強化了這一趨勢。

全球生物可吸收血管支架市場面臨的限制因素

全球生物可吸收血管支架市場的主要限制因素之一是缺乏長期臨床數據來支持其與傳統金屬支架相比的安全性和有效性。人們對延遲血栓症形成風險以及支架吸收最佳時機的擔憂，可能會阻礙醫生採用和患者接受。此外，生物可吸收材料的製造流程複雜且成本高昂，也會限制市場成長，尤其是對成本敏感的地區。另外，新型生物可吸收支架的法規核准流程可能漫長而嚴格，這進一步阻礙了市場擴張。

生物可吸收血管支架的全球市場趨勢

在全球可吸收血管支架市場中，影像技術和電腦建模的進步正推動著支架設計向個人化方向的重大轉變。這項變革使得支架形狀和聚合物成分的客製化成為可能，從而能夠更好地匹配每位患者獨特的解剖結構和病變特徵。透過將高解析度血管內成像技術與人工智慧驅動的設計演算法相結合，製造商正在開發客製化的可吸收支架，這些支架不僅能夠促進血管癒合，還能最大限度地降低血管再阻塞的風險。這種以患者為中心的創新策略正獲得醫生的支持，促進高階高級產品的開發，並最終推動可吸收解決方案在全球範圍內的普及，從而實現市場的永續收入成長。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球生物可吸收血管支架市場規模：依產品類型分類

• 高分子量生物可吸收血管支架
• 鎂基生物可吸收血管支架
• 藥物釋放型可吸收血管支架
• 非藥物釋放型生物可吸收血管支架

全球生物可吸收血管支架市場規模：依材料類型分類

• 聚左旋乳酸（PLLA）
• 鎂合金
• 酪氨酸衍生的聚合物
• 其他生物可吸收材料

全球生物可吸收血管支架市場規模：依應用領域分類

• 冠狀動脈疾病
• 周邊動脈疾病
• 複雜冠狀動脈病變
• 小血管疾病
• 其他

全球生物可吸收血管支架市場規模：依最終用戶分類

• 醫院
• 心臟中心
• 門診手術中心
• 循環系統專科診所

全球生物可吸收血管支架市場規模：依支架類型分類

• 用於冠狀動脈的生物可吸收支架
• 末梢用生物可吸收支架

全球生物可吸收血管支架市場規模：依藥物類型分類

• Sirolimus洗脫型
• Everolimus洗脫型
• 其他藥物釋放型支架
• 非藥物釋放型支架

全球生物可吸收血管支架市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要公司簡介

• Biotronik
• REVA Medical
• Elixir Medical
• Amaranth Medical
• Kyoto Medical Planning
• Arterius
• Meril Life Sciences
• Lepu Medical Technology
• MicroPort Scientific
• Lifetech Scientific
• QualiMed Innovative Medizinprodukte
• Sahajanand Medical Technologies
• Amaranth Medical Pte.
• Arterial Remodeling Technologies
• Zeus Medical
• OrbusNeich
• CGBio
• MeRes100（Meril Life Sciences Platform）
• R3 Vascular
• Xinsorb Medical Technology

結論與建議

Global Bioresorbable Vascular Scaffold Market size was valued at USD 301.0 Million in 2024 and is poised to grow from USD 331.4 Million in 2025 to USD 715.57 Million by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global market for bioresorbable vascular scaffolds (BVS) is gaining traction as these innovative devices offer temporary support to coronary arteries, dissolving over time to mitigate long-term complications associated with permanent metallic stents. Driven by a growing demand for biocompatible solutions, particularly among aging patients with complex coronary lesions, BVS technology addresses issues like restenosis and late stent thrombosis while enhancing vascular function. The shift toward minimally invasive cardiology supports the adoption of BVS, leading manufacturers to invest in research and development of advanced materials. Furthermore, AI is revolutionizing scaffold design through computational modeling, enabling faster innovation cycles and improved outcomes, thereby accelerating the development of diverse, high-performing scaffolds ready to meet stringent regulatory requirements and meet market needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioresorbable Vascular Scaffold market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bioresorbable Vascular Scaffold Market Segments Analysis

Global bioresorbable vascular scaffold market is segmented by product type, material type, application, end user, scaffold type, drug type and region. Based on product type, the market is segmented into Polymeric Bioresorbable Vascular Scaffolds, Magnesium-based Bioresorbable Vascular Scaffolds, Drug-eluting Bioresorbable Vascular Scaffolds and Non-drug-eluting Bioresorbable Vascular Scaffolds. Based on material type, the market is segmented into Poly-L-lactic Acid (PLLA), Magnesium Alloys, Tyrosine-derived Polymers and Other Bioresorbable Materials. Based on application, the market is segmented into Coronary Artery Disease, Peripheral Artery Disease, Complex Coronary Lesions, Small Vessel Disease and Others. Based on end user, the market is segmented into Hospitals, Cardiac Centers, Ambulatory Surgical Centers and Specialty Cardiovascular Clinics. Based on scaffold type, the market is segmented into Coronary Bioresorbable Scaffolds and Peripheral Bioresorbable Scaffolds. Based on drug type, the market is segmented into Sirolimus-eluting, Everolimus-eluting, Other Drug-eluting Scaffolds and Non-drug-eluting Scaffolds. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bioresorbable Vascular Scaffold Market

A key market driver for the global bioresorbable vascular scaffold market is the increasing prevalence of cardiovascular diseases, which has intensified the demand for innovative and effective treatment options. As healthcare professionals seek alternatives to traditional drug-eluting stents, bioresorbable scaffolds are gaining attention due to their ability to provide temporary support to blood vessels while promoting natural healing and reducing long-term complications. Additionally, advancements in material science and technology are enhancing the performance and safety of these scaffolds, further driving their adoption in clinical settings. This trend is amplified by a growing focus on personalized medicine and patient-centric care approaches.

Restraints in the Global Bioresorbable Vascular Scaffold Market

One of the key market restraints for the global bioresorbable vascular scaffold market is the limited long-term clinical data available to support the safety and efficacy of these devices compared to traditional metallic stents. Concerns regarding the potential for late thrombosis and the optimal timing of scaffold absorption can hinder physician adoption and patient acceptance. Additionally, the manufacturing complexities and higher costs associated with bioresorbable materials may restrict market growth, particularly in cost-sensitive regions. The regulatory approval process for new bioresorbable scaffolds can also be lengthy and rigorous, posing further challenges for market expansion.

Market Trends of the Global Bioresorbable Vascular Scaffold Market

The Global Bioresorbable Vascular Scaffold market is experiencing a significant shift towards personalized scaffold design, propelled by advancements in imaging technologies and computational modeling. This evolution allows for the customization of scaffold geometry and polymer composition, tailored specifically to the unique anatomy and lesion characteristics of individual patients. By leveraging high-resolution intravascular imaging alongside AI-driven design algorithms, manufacturers are creating bespoke bioresorbable scaffolds that not only enhance vessel healing but also minimize the risk of restenosis. This innovative, patient-centric strategy is boosting physician acceptance and fostering niche premium offerings, ultimately contributing to the broader global adoption of bioresorbable solutions and driving sustained revenue growth within the market.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bioresorbable Vascular Scaffold Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Polymeric Bioresorbable Vascular Scaffolds
• Magnesium-based Bioresorbable Vascular Scaffolds
• Drug-eluting Bioresorbable Vascular Scaffolds
• Non-drug-eluting Bioresorbable Vascular Scaffolds

Global Bioresorbable Vascular Scaffold Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Poly-L-lactic Acid (PLLA)
• Magnesium Alloys
• Tyrosine-derived Polymers
• Other Bioresorbable Materials

Global Bioresorbable Vascular Scaffold Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease
• Peripheral Artery Disease
• Complex Coronary Lesions
• Small Vessel Disease
• Others

Global Bioresorbable Vascular Scaffold Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Specialty Cardiovascular Clinics

Global Bioresorbable Vascular Scaffold Market Size by Scaffold Type & CAGR (2026-2033)

• Market Overview
• Coronary Bioresorbable Scaffolds
• Peripheral Bioresorbable Scaffolds

Global Bioresorbable Vascular Scaffold Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Sirolimus-eluting
• Everolimus-eluting
• Other Drug-eluting Scaffolds
• Non-drug-eluting Scaffolds

Global Bioresorbable Vascular Scaffold Market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, Application, End User, Scaffold Type, Drug Type)
  • US
  • Canada
• Europe (Product Type, Material Type, Application, End User, Scaffold Type, Drug Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, Application, End User, Scaffold Type, Drug Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, Application, End User, Scaffold Type, Drug Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, Application, End User, Scaffold Type, Drug Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• REVA Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QualiMed Innovative Medizinprodukte
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical Pte.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeus Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrbusNeich
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CGBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MeRes100 (Meril Life Sciences Platform)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R3 Vascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xinsorb Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations